197 related articles for article (PubMed ID: 4258329)
1. Plasmin lysis of fibrinogen and fibrin and the antigenic properties of their degradation products.
Ekert H; Muntz RH
Br J Haematol; 1972 Jan; 22(1):103-10. PubMed ID: 4258329
[No Abstract] [Full Text] [Related]
2. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
Colick JA; Fisher LM
Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
[No Abstract] [Full Text] [Related]
3. Fibrinogen derivatives. A laboratory and clinical study.
Vermylen J
Verh K Vlaam Acad Geneeskd Belg; 1972; 34(2):125-208. PubMed ID: 4278099
[No Abstract] [Full Text] [Related]
4. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
5. Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Tanaka H; Nagahama Y; Dokai M; Kashiwakura Y; Ishiwata A; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
Thromb Res; 2011 Apr; 127(4):349-55. PubMed ID: 21236472
[TBL] [Abstract][Full Text] [Related]
6. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
Kawai Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
[No Abstract] [Full Text] [Related]
7. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
Shinada S
Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
[No Abstract] [Full Text] [Related]
8. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
9. Experimental study of rabbit fibrinogen degradation products. Influence of plasminogen level for the interpretation of serum concentration of fibrinogen degradation products in consumption coagulopathies.
Soria J; Soria C; Vairel E; Prost RJ; Warneson G
Thromb Diath Haemorrh; 1973 Feb; 29(1):115-21. PubMed ID: 4267735
[No Abstract] [Full Text] [Related]
10. [Determination of FDP by staphylococcal clumping test and the significance of the method in consumption coagulopathy].
Yamada K; Yamada Z; Nakazawa S; Matsuoka S
Rinsho Ketsueki; 1972 Jun; 13(3):411-4. PubMed ID: 4674971
[No Abstract] [Full Text] [Related]
11. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
Horan JT; Francis CW
Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
[TBL] [Abstract][Full Text] [Related]
12. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
Madoiwa S
Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
[No Abstract] [Full Text] [Related]
13. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
Kawai Y; Watanabe K
Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
[No Abstract] [Full Text] [Related]
14. Defibrination syndrome: changing concepts and recognition of the low grade form.
Regan DH; Lackner H
Am J Med Sci; 1973 Aug; 266(2):84-91. PubMed ID: 4275757
[No Abstract] [Full Text] [Related]
15. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
Heene DL; Genth K
Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
[No Abstract] [Full Text] [Related]
16. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
Zhitkova IuV; Aĭsina RB; Varfolomeev SD
Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
[TBL] [Abstract][Full Text] [Related]
17. The effect of intravascular and extravascular coagulation on serum fibrin degradation products in rats.
Vanstone JC; Khoury NY
Thromb Diath Haemorrh; 1971; 25(1):142-6. PubMed ID: 4996073
[No Abstract] [Full Text] [Related]
18. Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasmin.
Prentice CR; Edgar W; McNicol GP
Br J Haematol; 1974 May; 27(1):77-87. PubMed ID: 4277400
[No Abstract] [Full Text] [Related]
19. Problems of diagnosis of disseminated intravascular coagulation (DIC).
Bowie EJ; Owen CA
Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
[TBL] [Abstract][Full Text] [Related]
20. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum.
Gormsen J; Feddersen C; Clemmensen I; Andersen RB
Scand J Haematol; 1972; 9(6):577-86. PubMed ID: 4118846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
